COMMUNIQUÉS West-GlobeNewswire

Microbix Presenting at Muskoka Capital Conference

25/09/2019 - 13:00

Meetings with Growth-Oriented Investors, September 27-29, 2019 MISSISSAUGA, Ontario, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of clinical diagnostic materials and [...]

Achillion Receives Breakthrough Therapy Designation from FDA for Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria

25/09/2019 - 13:00

– Danicopan Phase 2 PNH combination therapy topline data expected Q4 2019 – – Initiation of Phase 3 planned for early 2020 – BLUE BELL, Pa., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: [...]

Rhythm Pharmaceuticals Provides Update on Research and Development Programs

25/09/2019 - 13:00

-- Four new MC4R pathway obesity indications added to Phase 2 Basket Study and enrolling patients -- -- Genetic sequencing of 13,567 individuals with severe obesity yields 11.7 percent (1,584 individuals) who have a [...]

Orchard Therapeutics to Present at the 2019 Cell & Gene Meeting on the Mesa

25/09/2019 - 13:00

BOSTON and LONDON, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life- [...]

Summit Therapeutics to Host R&D Day 7 October 2019

25/09/2019 - 13:00

Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics to Host R&D Day 7 October 2019 Oxford, UK, and Cambridge, MA, US, 25 September 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today [...]

Matinas BioPharma Announces Pre-Screening of Patients to Determine Eligibility for Phase 2 ENHANCE-IT Study Against Vascepa®

25/09/2019 - 13:00

BEDMINSTER, N.J., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical stage biopharmaceutical company, today announced that it has commenced pre-screening patients to [...]

Teleflex Announces Tenth Anniversary of GuideLiner® Catheter Product Line

25/09/2019 - 12:45

Company Celebrates 10 Years of the Industry's Leading Guide Extension Catheter with More Than 1 Million Units Sold Worldwide WAYNE, Pa., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading [...]

Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion

25/09/2019 - 08:30

Press release Malmö, 25 September 2019 Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion The board of directors of Acarix AB ("Acarix" or the "Company") has [...]

Chi-Med Highlights Presentation of Clinical Data from the Successful SANET-ep Phase III Trial at ESMO Annual Meeting

25/09/2019 - 08:15

– Late-Breaking Abstract of the positive SANET-ep Phase III trial of surufatinib in patients with non-pancreatic neuroendocrine tumors (“NET”) to be presented – – Conference call and webcast with lead trial [...]

Sequana Medical Announces 2019 Half Year Results and Year-to-date Business Update

25/09/2019 - 07:05

Continued strong progress since IPO in February 2019: Commenced POSEIDON pivotal study to support approval of the alfa pump® in the U.S. & Canada Achieved clinical proof-of-concept of Direct Sodium Removal (DSR), [...]

Sequana Medical Announces First Patient Enrolled in North American alfapump® Pivotal Study (POSEIDON)

25/09/2019 - 07:00

Study aims to support the approval of the alfa pump in U.S. and Canada Results anticipated by mid-2021 U.S. launch of the alfa pump planned for H1 2022 GHENT, Belgium, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Sequana Medical [...]

ADDEX THERAPEUTICS TO RELEASE HALF-YEAR 2019 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON SEPTEMBER 30, 2019

25/09/2019 - 07:00

Geneva, Switzerland, September 25, 2019 – Addex Therapeutics (SIX:ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, will discuss its half-year 2019 financial results, [...]

Align Technology Further Advances Digital Dentistry in China With the Launch of the iTero Element 2 Scanner

25/09/2019 - 06:15

Receives approval from China ’s National Medical Products Administration to manufacture and sell the iTero Element 2 Scanner in China Provides localized technology and manufacturing capabilities to better serve China [...]

‘Better together’: Mental Health Commission of Canada and Canadian Mental Health Association announce strengthened collaboration

25/09/2019 - 00:00

From Mental Health Commission of Canada TORONTO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- At the Canadian Mental Health Association’s (CMHA) national Mental Health For All conference in Toronto today, CMHA and the Mental [...]

« Mieux ensemble » : Renforcement de la collaboration entre la Commission de la santé mentale du Canada et l’Association canadienne pour la santé mentale

25/09/2019 - 00:00

De la Commission de la santé mentale du Canada TORONTO, 24 sept. 2019 (GLOBE NEWSWIRE) -- Lors de son Congrès annuel La santé mentale pour tous aujourd’hui à Toronto, l’Association canadienne pour la santé mentale (ACSM [...]

Bone Bank Allografts Launches Global Sales Force Initiative

24/09/2019 - 23:04

Distributor Expansion to Support Growing Demand for Orthobiologics SAN ANTONIO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Bone Bank Allografts (BBA), a leading provider of regenerative medicine technologies to the surgical [...]

Rockwell Medical, Inc. to Present at 2019 Cantor Global Healthcare Conference

24/09/2019 - 22:30

WIXOM, Mich., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, is scheduled to present at the 2019 [...]

BioCryst Pharmaceuticals to Present at Cantor Global Healthcare Conference

24/09/2019 - 22:15

RESEARCH TRIANGLE PARK, N.C., Sept. 24, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the company will present at the Cantor Global Healthcare Conference in New York on [...]

Opiant Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference

24/09/2019 - 22:05

SANTA MONICA, Calif., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, announced today [...]